These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 23703673

  • 1. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
    Fingas CD, Mertens JC, Razumilava N, Sydor S, Bronk SF, Christensen JD, Ilyas SI, Canbay A, Treckmann JW, Paul A, Sirica AE, Gores GJ.
    Hepatology; 2013 Oct; 58(4):1362-74. PubMed ID: 23703673
    [Abstract] [Full Text] [Related]

  • 2. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
    Fingas CD, Bronk SF, Werneburg NW, Mott JL, Guicciardi ME, Cazanave SC, Mertens JC, Sirica AE, Gores GJ.
    Hepatology; 2011 Dec; 54(6):2076-88. PubMed ID: 22038837
    [Abstract] [Full Text] [Related]

  • 3. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S, Jafoui S, Wingerter L, Swoboda S, Mertens JC, Gerken G, Canbay A, Paul A, Fingas CD.
    World J Gastroenterol; 2017 Jun 14; 23(22):4007-4015. PubMed ID: 28652654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells.
    Fingas CD, Blechacz BR, Smoot RL, Guicciardi ME, Mott J, Bronk SF, Werneburg NW, Sirica AE, Gores GJ.
    Hepatology; 2010 Aug 14; 52(2):550-61. PubMed ID: 20683954
    [Abstract] [Full Text] [Related]

  • 6. Targeting PDGFR-β in Cholangiocarcinoma.
    Fingas CD, Mertens JC, Razumilava N, Bronk SF, Sirica AE, Gores GJ.
    Liver Int; 2012 Mar 14; 32(3):400-9. PubMed ID: 22133064
    [Abstract] [Full Text] [Related]

  • 7. Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma.
    Razumilava N, Gradilone SA, Smoot RL, Mertens JC, Bronk SF, Sirica AE, Gores GJ.
    J Hepatol; 2014 Mar 14; 60(3):599-605. PubMed ID: 24239776
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
    Blechacz BR, Smoot RL, Bronk SF, Werneburg NW, Sirica AE, Gores GJ.
    Hepatology; 2009 Dec 14; 50(6):1861-70. PubMed ID: 19821497
    [Abstract] [Full Text] [Related]

  • 9. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M, Motter R, Tanaka P, Fauss D, Babcock M, Chiou SS, Nelson S, San Pablo F, Anderson JP.
    Neuroscience; 2014 Jan 03; 256():72-82. PubMed ID: 24128992
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A, Akiyama Y, Sripa B, Yuasa Y.
    J Cancer Res Clin Oncol; 2007 Apr 03; 133(4):271-8. PubMed ID: 17294242
    [Abstract] [Full Text] [Related]

  • 12. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M, Nardo G, Indraccolo S, Dall'olmo L, Sambado L, Moserle L, Franceschet I, Colledan M, Massani M, Stecca T, Bassi N, Morton S, Spirli C, Fiorotto R, Fabris L, Strazzabosco M.
    Hepatology; 2013 Sep 03; 58(3):1042-53. PubMed ID: 23505219
    [Abstract] [Full Text] [Related]

  • 13. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
    Kim Y, Kim MO, Shin JS, Park SH, Kim SB, Kim J, Park SC, Han CJ, Ryu JK, Yoon YB, Kim YT.
    Ann Surg Oncol; 2014 Aug 03; 21(8):2684-98. PubMed ID: 24682719
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
    Kobayashi S, Werneburg NW, Bronk SF, Kaufmann SH, Gores GJ.
    Gastroenterology; 2005 Jun 03; 128(7):2054-65. PubMed ID: 15940637
    [Abstract] [Full Text] [Related]

  • 15. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.
    Ustundag Y, Bronk SF, Gores GJ.
    World J Gastroenterol; 2007 Feb 14; 13(6):851-7. PubMed ID: 17352013
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H, Zhang J, Zhang Y, Feng Q, Wang H, Li G, Jiang W, Li X.
    Gene; 2019 May 25; 698():50-60. PubMed ID: 30822475
    [Abstract] [Full Text] [Related]

  • 17. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
    Lomphithak T, Choksi S, Mutirangura A, Tohtong R, Tencomnao T, Usubuchi H, Unno M, Sasano H, Jitkaew S.
    Cell Commun Signal; 2020 Oct 09; 18(1):161. PubMed ID: 33036630
    [Abstract] [Full Text] [Related]

  • 18. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment.
    Zhou Y, Xu L, Wang Z, Liu H, Zhang X, Shu C, Zhang M, Wang T, Xu X, Pu X, He J, Wang P, Qiu Y, Xu G, Zou X, Zhu Y, Wang L.
    Theranostics; 2022 Oct 09; 12(8):3911-3927. PubMed ID: 35664077
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.